On Wednesday, Shares of Boyd Gaming Corporation (NYSE:BYD), lost -1.57% to $16.89.
Boyd Gaming Corporation, stated financial results for the second quarter ended June 30, 2015.
Boyd Gaming stated second-quarter 2015 net revenues of $559.9 million, an enhance of $19.2 million, or 3.5%, from pro forma net revenues of $540.7 million for the same quarter in 2014. Total Adjusted EBITDA(1) was $162.9 million, up $23.6 million or 17.0% from the comparable pro forma amount of $139.3 million for the year-ago period. Effective September 30, 2014, the Company demerged Borgata and is accounting for its 50% investment in Borgata by applying the equity method for periods subsequent to that date. The preceding-year pro forma amounts reflect the results for Borgata on a comparable equity method basis.
Boyd Gaming Corporation, together with its auxiliaries, operates as a multi-jurisdictional gaming company. It operates in five segments: Las Vegas, Downtown Las Vegas, Midwest and South, Peninsula, and Borgata.
Shares of Turquoise Hill Resources Ltd (NYSE:TRQ), declined 0.44% to $ 3.44, during its last trading session.
Turquoise Hill Resources will declare its second quarter financial results on Wednesday, August 5, 2015 after markets close in North America.
The Company will host a conference call and webcast to talk about second quarter results on Thursday, August 6, 2015 at 10:00 am EDST/7:00 am PDST.
Turquoise Hill Resources Ltd., together with its auxiliaries, operates as a mining company. Its principal material mineral resource property is the Oyu Tolgoi copper-gold mine located in the southern Mongolia.
At the end of Wednesday’s trade, Shares of VIVUS, Inc. (NASDAQ:VVUS), lost -4.42% to $1.73.
VIVUS, declared that it will provide an update and report financial results for the second quarter ended June 30, 2015 after the NASDAQ Market closes on Thursday, July 30, 2015. The company will conduct a conference call and an audio webcast at 4:30PM EDT the same day.
VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union.
Finally, Eastman Chemical Company (NYSE:EMN), ended its last trade with 1.38% gain, and closed at $78.08.
Eastman Chemical Company, declared earnings, not taking into account non-core items, of $2.01 per diluted share for second quarter 2015 as compared to $1.92 per diluted share for second quarter 2014. Stated earnings were $1.98 per diluted share for second quarter 2015 as compared to $1.92 per diluted share for second quarter 2014. For detail of the excluded items and reconciliation to stated company and segment earnings, see Tables 3A and 4.
“Our record results in second quarter and strong performance in the first half of the year demonstrate the quality of our robust specialty portfolio, the value of our acquisitions, and most importantly our ability to focus on execution and deliver results,” said Mark Costa, chairman and CEO. “We remain confident we will deliver our sixth successive year of solid earnings growth in 2015.”
Eastman Chemical Company, a specialty chemical company, manufactures and sells materials, chemicals, and fibers in the United States and internationally. The company’s Additives & Functional Products segment offers solvents, such as specialty coalescents and ketones and esters, glycol ethers, and alcohol solvents; cellulose and polyester-based specialty polymers, and paint additives; insoluble sulfur products; antidegradants; hydrocarbon resins; specialty intermediates, performance products, and formic acid; and alkylamine derivatives.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
